Immunotherapy for Lung Cancers
نویسندگان
چکیده
منابع مشابه
Immunotherapy for Lung Cancers
Lung cancer is the leading cause of cancer-related deaths worldwide. Although treatment methods in surgery, irradiation, and chemotherapy have improved, prognosis remains unsatisfactory and developing new therapeutic strategies is still an urgent demand. Immunotherapy is a novel therapeutic approach wherein activated immune cells can specifically kill tumor cells by recognition of tumor-associa...
متن کاملImmunotherapy in Gastrointestinal Cancers
Gastrointestinal cancers represent a major public health problem worldwide. Immunotherapeutic strategies are currently under investigation in this setting and preliminary results of ongoing trials adopting checkpoint inhibitors are striking. Indeed, although a poor immunogenicity for GI has been reported, a strong biological rationale supports the development of immunotherapy in this field. The...
متن کاملImmunotherapy of Brain Cancers and Neurological Disorders
Submit Manuscript | http://medcraveonline.com Abbreviations: α-syn: α-synucleinopathies; Aβ: Amyloid Beta; AD: Alzheimer’s Disease; ALL: Acute Lymphoblastic Leukemia; ALS: Amyotrophic Lateral Sclerosis; BBB: Blood Brain Barrier; BPB: Brain Protective Barriers; CAR: Chimeric Antigen Receptor; CLL: Chronic Lymphocytic Leukemia; CNS: Central Nervous System; CSF: Cerebro-Spinal Fluid; CTLA: Cytotox...
متن کاملImmunotherapy Plus Cryotherapy: Potential Augmented Abscopal Effect for Advanced Cancers
Since the 1920s the gold standard for treating cancer has been surgery, which is typically preceded or followed with chemotherapy and/or radiation, a process that perhaps contributes to the destruction of a patient’s immune defense system. Cryosurgery ablation of a solid tumor is mechanistically similar to a vaccination where hundreds of unique antigens from a heterogeneous population of tumor ...
متن کاملImmunotherapy for Epstein-Barr virus-associated cancers in children.
Latent Epstein-Barr virus (EBV) infection is associated with several malignancies, including Burkitt's lymphoma, Hodgkin's disease, nasopharyngeal carcinoma, and post-transplant lymphoproliferative disease (LPD). The presence of EBV antigens in these tumors provides a target for immunotherapy approaches, and immunotherapy with EBV-specific cytotoxic T cells (CTLs) has proved effective in post-t...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Biomedicine and Biotechnology
سال: 2011
ISSN: 1110-7243,1110-7251
DOI: 10.1155/2011/250860